Ryan A. Wilcox

BTCRC-HEM15-028

Phase I/II Study of Ixazomib and Romidepsin in Relapsed/ Refractory Peripheral T-cell Lymphoma (PTCL): Big Ten Cancer Research Consortium BTCRC-HEM15-028
Status
Closed
Cancer Types
Lymphoma
Locations

BTCRC-HEM16-085

Phase II study of nivolumab and the antagonistic CSF-1R monoclonal antibody cabiralizumab (BMS-986227) in patients with relapsed/refractory peripheral T cell lymphoma
Status
Closed
Cancer Types
Lymphoma
Locations